Peripheral Neuropathy Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014595479
Market Monitor Global
Nov-2021
Life Sciences
90 Pages

This report contains market size and forecasts of Peripheral Neuropathy Treatment in Global, including the following market information:
Global Peripheral Neuropathy Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Peripheral Neuropathy Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Peripheral Neuropathy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peripheral Neuropathy Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Peripheral Neuropathy Treatment Market Segment Percentages, By Type, 2020 (%)
Calcium Channel ?2-delta Ligands
Antidepressants
Opioids
Others

China Peripheral Neuropathy Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Peripheral Neuropathy Treatment Market Segment Percentages, By Application, 2020 (%)
Platinum Agents
Taxanes
Vinca Alkaloids
Others

Global Peripheral Neuropathy Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Peripheral Neuropathy Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Peripheral Neuropathy Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Peripheral Neuropathy Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Eli Lilly
Johnson & Johnson
Novartis
Pfizer
Aptinyx
Regenacy Pharmaceuticals
TEVA Pharmaceutical Industries
Immune Pharmaceuticals

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Peripheral Neuropathy Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Neuropathy Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Neuropathy Treatment Overall Market Size
2.1 Global Peripheral Neuropathy Treatment Market Size: 2021 VS 2027
2.2 Global Peripheral Neuropathy Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peripheral Neuropathy Treatment Players in Global Market
3.2 Top Global Peripheral Neuropathy Treatment Companies Ranked by Revenue
3.3 Global Peripheral Neuropathy Treatment Revenue by Companies
3.4 Top 3 and Top 5 Peripheral Neuropathy Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Peripheral Neuropathy Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peripheral Neuropathy Treatment Players in Global Market
3.6.1 List of Global Tier 1 Peripheral Neuropathy Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Peripheral Neuropathy Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peripheral Neuropathy Treatment Market Size Markets, 2021 & 2027
4.1.2 Calcium Channel ?2-delta Ligands
4.1.3 Antidepressants
4.1.4 Opioids
4.1.5 Others
4.2 By Type - Global Peripheral Neuropathy Treatment Revenue & Forecasts
4.2.1 By Type - Global Peripheral Neuropathy Treatment Revenue, 2016-2021
4.2.2 By Type - Global Peripheral Neuropathy Treatment Revenue, 2022-2027
4.2.3 By Type - Global Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripheral Neuropathy Treatment Market Size, 2021 & 2027
5.1.2 Platinum Agents
5.1.3 Taxanes
5.1.4 Vinca Alkaloids
5.1.5 Others
5.2 By Application - Global Peripheral Neuropathy Treatment Revenue & Forecasts
5.2.1 By Application - Global Peripheral Neuropathy Treatment Revenue, 2016-2021
5.2.2 By Application - Global Peripheral Neuropathy Treatment Revenue, 2022-2027
5.2.3 By Application - Global Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Peripheral Neuropathy Treatment Market Size, 2021 & 2027
6.2 By Region - Global Peripheral Neuropathy Treatment Revenue & Forecasts
6.2.1 By Region - Global Peripheral Neuropathy Treatment Revenue, 2016-2021
6.2.2 By Region - Global Peripheral Neuropathy Treatment Revenue, 2022-2027
6.2.3 By Region - Global Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Peripheral Neuropathy Treatment Revenue, 2016-2027
6.3.2 US Peripheral Neuropathy Treatment Market Size, 2016-2027
6.3.3 Canada Peripheral Neuropathy Treatment Market Size, 2016-2027
6.3.4 Mexico Peripheral Neuropathy Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Peripheral Neuropathy Treatment Revenue, 2016-2027
6.4.2 Germany Peripheral Neuropathy Treatment Market Size, 2016-2027
6.4.3 France Peripheral Neuropathy Treatment Market Size, 2016-2027
6.4.4 U.K. Peripheral Neuropathy Treatment Market Size, 2016-2027
6.4.5 Italy Peripheral Neuropathy Treatment Market Size, 2016-2027
6.4.6 Russia Peripheral Neuropathy Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Peripheral Neuropathy Treatment Market Size, 2016-2027
6.4.8 Benelux Peripheral Neuropathy Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Peripheral Neuropathy Treatment Revenue, 2016-2027
6.5.2 China Peripheral Neuropathy Treatment Market Size, 2016-2027
6.5.3 Japan Peripheral Neuropathy Treatment Market Size, 2016-2027
6.5.4 South Korea Peripheral Neuropathy Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Peripheral Neuropathy Treatment Market Size, 2016-2027
6.5.6 India Peripheral Neuropathy Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Peripheral Neuropathy Treatment Revenue, 2016-2027
6.6.2 Brazil Peripheral Neuropathy Treatment Market Size, 2016-2027
6.6.3 Argentina Peripheral Neuropathy Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peripheral Neuropathy Treatment Revenue, 2016-2027
6.7.2 Turkey Peripheral Neuropathy Treatment Market Size, 2016-2027
6.7.3 Israel Peripheral Neuropathy Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Peripheral Neuropathy Treatment Market Size, 2016-2027
6.7.5 UAE Peripheral Neuropathy Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Peripheral Neuropathy Treatment Major Product Offerings
7.1.4 Eli Lilly Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.1.5 Eli Lilly Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Peripheral Neuropathy Treatment Major Product Offerings
7.2.4 Johnson & Johnson Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.2.5 Johnson & Johnson Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Peripheral Neuropathy Treatment Major Product Offerings
7.3.4 Novartis Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Peripheral Neuropathy Treatment Major Product Offerings
7.4.4 Pfizer Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.4.5 Pfizer Key News
7.5 Aptinyx
7.5.1 Aptinyx Corporate Summary
7.5.2 Aptinyx Business Overview
7.5.3 Aptinyx Peripheral Neuropathy Treatment Major Product Offerings
7.5.4 Aptinyx Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.5.5 Aptinyx Key News
7.6 Regenacy Pharmaceuticals
7.6.1 Regenacy Pharmaceuticals Corporate Summary
7.6.2 Regenacy Pharmaceuticals Business Overview
7.6.3 Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Major Product Offerings
7.6.4 Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.6.5 Regenacy Pharmaceuticals Key News
7.7 TEVA Pharmaceutical Industries
7.7.1 TEVA Pharmaceutical Industries Corporate Summary
7.7.2 TEVA Pharmaceutical Industries Business Overview
7.7.3 TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Major Product Offerings
7.4.4 TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.7.5 TEVA Pharmaceutical Industries Key News
7.8 Immune Pharmaceuticals
7.8.1 Immune Pharmaceuticals Corporate Summary
7.8.2 Immune Pharmaceuticals Business Overview
7.8.3 Immune Pharmaceuticals Peripheral Neuropathy Treatment Major Product Offerings
7.8.4 Immune Pharmaceuticals Peripheral Neuropathy Treatment Revenue in Global (2016-2021)
7.8.5 Immune Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Peripheral Neuropathy Treatment Market Opportunities & Trends in Global Market
Table 2. Peripheral Neuropathy Treatment Market Drivers in Global Market
Table 3. Peripheral Neuropathy Treatment Market Restraints in Global Market
Table 4. Key Players of Peripheral Neuropathy Treatment in Global Market
Table 5. Top Peripheral Neuropathy Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Peripheral Neuropathy Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Peripheral Neuropathy Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Peripheral Neuropathy Treatment Product Type
Table 9. List of Global Tier 1 Peripheral Neuropathy Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peripheral Neuropathy Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Peripheral Neuropathy Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Peripheral Neuropathy Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Peripheral Neuropathy Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Peripheral Neuropathy Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Peripheral Neuropathy Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Peripheral Neuropathy Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Peripheral Neuropathy Treatment Product Offerings
Table 32. Eli Lilly Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Peripheral Neuropathy Treatment Product Offerings
Table 35. Johnson & Johnson Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Novartis Corporate Summary
Table 37. Novartis Peripheral Neuropathy Treatment Product Offerings
Table 38. Novartis Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Peripheral Neuropathy Treatment Product Offerings
Table 41. Pfizer Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Aptinyx Corporate Summary
Table 43. Aptinyx Peripheral Neuropathy Treatment Product Offerings
Table 44. Aptinyx Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Regenacy Pharmaceuticals Corporate Summary
Table 46. Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Product Offerings
Table 47. Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
Table 48. TEVA Pharmaceutical Industries Corporate Summary
Table 49. TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Product Offerings
Table 50. TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Immune Pharmaceuticals Corporate Summary
Table 52. Immune Pharmaceuticals Peripheral Neuropathy Treatment Product Offerings
Table 53. Immune Pharmaceuticals Peripheral Neuropathy Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Peripheral Neuropathy Treatment Segment by Type
Figure 2. Peripheral Neuropathy Treatment Segment by Application
Figure 3. Global Peripheral Neuropathy Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Peripheral Neuropathy Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Peripheral Neuropathy Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peripheral Neuropathy Treatment Revenue in 2020
Figure 8. By Type - Global Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 12. US Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 24. China Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Peripheral Neuropathy Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Peripheral Neuropathy Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Eli Lilly Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Johnson & Johnson Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Pfizer Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Aptinyx Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Immune Pharmaceuticals Peripheral Neuropathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Eli Lilly
Johnson & Johnson
Novartis
Pfizer
Aptinyx
Regenacy Pharmaceuticals
TEVA Pharmaceutical Industries
Immune Pharmaceuticals

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE